Search

everythinglearnresearchcommunity

for

Search:↓

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Mogamulizumab can cause hair loss and skin rashes.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Belatacept may be a promising treatment for alopecia areata.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.